Literature DB >> 8702965

Purine-specific nucleoside N-ribohydrolase from Trypanosoma brucei brucei. Purification, specificity, and kinetic mechanism.

D W Parkin1.   

Abstract

Trypanosomes have no de novo purine biosynthesis and thus depend upon salvage pathways to obtain purines for their metabolic pathways and for the biosynthesis of nucleic acids. An inosine-adenosine-guanosine preferring nucleoside hydrolase (IAG-nucleoside hydrolase) from the African trypanosome Trypanosoma brucei brucei represents approximately 0.2% of the soluble protein in this organism. The enzyme has been purified over 400-fold to >95% homogeneity from the bloodstream form of this parasite. IAG-nucleoside hydrolase is a dimer of Mr 36,000 subunits. The kcat/Km for inosine, adenosine, and guanosine are 1.9 x 10(6), 1.2 x 10(6), and 0.83 x 10(6) M -1 s-1, respectively. The kinetic mechanism with inosine as substrate is rapid equilibrium with random product release. The turnover rate for inosine at 30 degrees C is 34 s-1. Pyrimidine nucleosides are poor substrates with kcat/Km values of approximately 10(3) M -1 s-1. Deoxynucleosides are also poor substrates with kcat/Km values near 10(2) M -1 s-1. AMP is not a detectable substrate and there is no measurable purine nucleoside phosphorylase activity. 3-Deazaadenosine, 7-deazaadenosine (tubercidin), and formycin B are competitive inhibitors with Kis of 1.8, 59, and 13 microM, respectively. The Km shows a slight dependence on pH with a pH optimum around 7. The Vmax/Km data indicate there are two ionizable enzymatic groups, pKa 8.6, required for the formation of the Michaelis complex. The Vmax data indicate three ionizable groups involved in catalysis. Two essential groups exhibit pKa values of 8.8, and a third group with a pKa of 6.5 increases the Vmax an additional 10-fold. All three groups must be protonated for optimum catalytic activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702965

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  The rate of spontaneous cleavage of the glycosidic bond of adenosine.

Authors:  Randy B Stockbridge; Gottfried K Schroeder; Richard Wolfenden
Journal:  Bioorg Chem       Date:  2010-06-04       Impact factor: 5.275

2.  Structural and biochemical characterization of the nucleoside hydrolase from C. elegans reveals the role of two active site cysteine residues in catalysis.

Authors:  Ranjan Kumar Singh; Jan Steyaert; Wim Versées
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

3.  Structure and function of nucleoside hydrolases from Physcomitrella patens and maize catalyzing the hydrolysis of purine, pyrimidine, and cytokinin ribosides.

Authors:  Martina Kopecná; Hanna Blaschke; David Kopecny; Armelle Vigouroux; Radka Koncitíková; Ondrej Novák; Ondrej Kotland; Miroslav Strnad; Solange Moréra; Klaus von Schwartzenberg
Journal:  Plant Physiol       Date:  2013-10-29       Impact factor: 8.340

4.  9-(2'-Deoxy-2'-Fluoro-β-d-Arabinofuranosyl) Adenine Is a Potent Antitrypanosomal Adenosine Analogue That Circumvents Transport-Related Drug Resistance.

Authors:  Farahnaz Ranjbarian; Munender Vodnala; Khalid J H Alzahrani; Godwin U Ebiloma; Harry P de Koning; Anders Hofer
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

5.  Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis.

Authors:  Maya Berg; Linda Kohl; Pieter Van der Veken; Jurgen Joossens; Mohammed I Al-Salabi; Valeria Castagna; Francesca Giannese; Paul Cos; Wim Versées; Jan Steyaert; Philippe Grellier; Achiel Haemers; Massimo Degano; Louis Maes; Harry P de Koning; Koen Augustyns
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

6.  New trends in nucleoside biotechnology.

Authors:  I A Mikhailopulo; A I Miroshnikov
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

7.  Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.

Authors:  Elisangela Oliveira Freitas; Dirlei Nico; Rong Guan; José Roberto Meyer-Fernandes; Keith Clinch; Gary B Evans; Peter C Tyler; Vern L Schramm; Clarisa B Palatnik-de-Sousa
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

8.  Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose.

Authors:  Darren J Creek; Muriel Mazet; Fiona Achcar; Jana Anderson; Dong-Hyun Kim; Ruwida Kamour; Pauline Morand; Yoann Millerioux; Marc Biran; Eduard J Kerkhoven; Achuthanunni Chokkathukalam; Stefan K Weidt; Karl E V Burgess; Rainer Breitling; David G Watson; Frédéric Bringaud; Michael P Barrett
Journal:  PLoS Pathog       Date:  2015-03-16       Impact factor: 6.823

9.  In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants.

Authors:  William N Setzer; Ifedayo V Ogungbe
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

10.  Infection with dengue-2 virus alters proteins in naturally expectorated saliva of Aedes aegypti mosquitoes.

Authors:  Daniel M Chisenhall; Rebecca C Christofferson; Michael K McCracken; Ann-Marie F Johnson; Berlin Londono-Renteria; Christopher N Mores
Journal:  Parasit Vectors       Date:  2014-05-30       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.